Endpoints in advanced breast cancer: methodological aspects & clinical implications.

about

Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer.Antitumor mechanisms of S-allyl mercaptocysteine for breast cancer therapy.Anticancer effects of an extract from the scallop Patinopecten yessoensis on MCF-7 human breast carcinoma cells.

P2860

Q33800697-EF6116D0-7465-49D9-836F-0A37754602F0 Q34006770-848D4C23-1E39-411C-B7B1-A4B3EE0055EA Q41144514-183B28AE-D914-4C96-B8A8-3624E2396EDF

P2860

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

Item

http://www.wikidata.org/entity/Q35611036

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

@ast

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

@en

type

Item

label

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

@ast

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

@en

prefLabel

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

@ast

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

@en

P1476

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

@en

P2093

Everardo D Saad

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

Global cancer statistics

American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

General and statistical hierarchy of appropriate biologic endpoints.

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer

Goals of treatment for patients with metastatic breast cancer.

Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.

P304

413-418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P407

English

P478

134

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22089601

http://www.w3.org/2001/XMLSchema#string

P921

breast cancer

P932

3237237

http://www.w3.org/2001/XMLSchema#string

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

about

P2860

P2860

Endpoints in advanced breast cancer: methodological aspects & clinical implications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P407

P478

P5008

P577

P698

P921

P932

P1433

P1476

P2093

P275

P2860

P304

P31

P407

P478

P5008

P577

P698

P921

P932